MedTrace Logo

Tuberculosis Sentinel Research Network (TB-SRN)

NCT07798167 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 374

Last updated 2026-09-01

No results posted yet for this study

Summary

The overarching objective/aim of the study is to assess pulmonary TB treatment and longer-term outcomes among people with and without HIV in African population in order to inform policy and practice around TB treatment and create a platform for additional TB research in Zambia

Conditions

  • TO ACCESS THE INDIVIDUAL-LEVEL EFFECTS OF HIV AND ANTIRETROVIRAL THERAPY

Sponsors & Collaborators

  • Centre for Infectious Disease Research in Zambia

    lead OTHER

Eligibility

Min Age
15 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-15
Primary Completion
2026-12-22
Completion
2027-04-30

Countries

  • Zambia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07798167 on ClinicalTrials.gov